Related Experiment Video
Updated: Mar 1, 2026

07:05
Ultrasound-guided Botulinum Toxin-A Injections: A Method of Treating Sialorrhea
Published on: November 9, 2016
25.1K
Delayed-onset post-craniotomy headache responsive to botulinum toxin A: a case series
Danièle Ranoux1, Gaëlle Martiné2, Gaëlle Espagne2
1Department of Neurosurgery, CHU Limoges, Limoges, France.
Acta Neurochirurgica
|May 31, 2017
Summary
Four patients experienced delayed temporal pain after surgery. Botulinum toxin A injections effectively treated this pain, suggesting aberrant nerve regeneration as the cause.
Area of Science:
- Neurosurgery
- Neurology
- Pain Management
Background:
- Pterional craniotomy is a common neurosurgical approach.
- Delayed-onset pain is a potential complication following cranial surgery.
- Temporal pain and temporalis muscle hypertrophy are underreported sequelae.
Purpose of the Study:
- To describe a series of patients with delayed-onset temporal pain post-pterional craniotomy.
- To investigate the potential cause of this specific type of post-operative pain.
- To evaluate the efficacy of botulinum toxin A as a treatment modality.
Main Methods:
- Case series of four patients.
- Clinical evaluation of pain characteristics and temporalis muscle status.
- Treatment with botulinum toxin A injections into the temporalis muscle.
Main Results:
- All four patients reported delayed-onset temporal pain ipsilateral to the surgical site.
- Patients exhibited hypertrophy of the temporalis muscle.
- Dramatic pain relief was achieved following botulinum toxin A injections (25-50 units).
Conclusions:
- Aberrant nerve regeneration, likely involving the frontal branch of the facial nerve, is a probable cause of delayed temporal pain after pterional craniotomy.
- Botulinum toxin A offers an effective treatment for this condition.
- Further research is warranted to elucidate the precise mechanisms of nerve injury and regeneration.
Related Concept Videos
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
1.3K
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
1.3K
Depolarizing Blockers: Pharmocokinetics
672
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
672

